Clinical Trials Browser

Phase 1 × Solid Tumor × Fulvestrant × Clear all

NCT04316169 2022-12-23

Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer

Phase 1 Withdrawn

BreastOther solid neoplasm

Solid Tumor